ArticleProtein engineering, design & selection : PEDS2019

Development of a novel prostate apoptosis response-4 (Par-4) protein entity with an extended duration of action for therapeutic treatment of cancer.

Kyungbo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.